dr. coffman on safety concerns with parp inhibitors in ovarian cancer
Published 4 years ago • 107 plays • Length 0:45Download video MP4
Download video MP3
Similar videos
-
1:25
dr. konecny on the indications for parp inhibitors in recurrent ovarian cancer
-
8:03
parp inhibitors in ovarian cancer: safety profile
-
1:15
dr. konner on parp inhibitors in ovarian cancer
-
1:30
dr. penson on research with parp inhibitors in ovarian cancer
-
1:24
dr. ledermann on response to rucaparib in recurrent ovarian cancer
-
1:48
dr. westin on advances made with parp inhibitors in ovarian cancer
-
1:18
dr. backes on treatment selection with parp inhibitors in ovarian cancer
-
0:56
dr. levine on combos with parp inhibitors in ovarian cancer
-
1:08
dr. essel on repeat use of parp inhibitors in ovarian cancer
-
2:22
dr. konecny on the value of parp inhibitors in ovarian cancer
-
1:56
dr. birrer on parp inhibitors in ovarian cancer
-
0:50
dr. secord on the role of parp inhibitors in ovarian cancer
-
1:22
dr. gunderson on the use of parp inhibitors in all-comers with ovarian cancer
-
2:25
dr. naumann on unanswered questions with parp inhibitors in ovarian cancer
-
1:40
dr. hardesty on bevacizumab/parp inhibitor combination in ovarian cancer
-
2:23
dr. moore on unanswered questions with parp inhibitors in ovarian cancer
-
18:37
ongoing clinical trials with parp inhibitors in ovarian cancer
-
0:56
dr. backes on quality of life with parp inhibitors in ovarian cancer
-
1:37
dr. konecny on the use of parp inhibitors in patients with ovarian cancer